Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells

Cytotherapy

Volumn 6, Issue 4, 2004, Pages 311-317

  McNiece, Ian K ^a   Harrington, J ^a   Turney, J ^a   Kellner, J ^a   Shpall, E J ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Cord blood transplantation; Ex vivo expansion; Growth factors; Mesenchymal stem cells

Indexed keywords

CD34 ANTIGEN; HEMOPOIETIC GROWTH FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT STEM CELL FACTOR;

ARTICLE; CANCER CHEMOTHERAPY; CELL ASSAY; CELL COUNT; CELL CULTURE; CELL ISOLATION; CELL LOSS; CELL SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MEGADOSE; EX VIVO STUDY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MESENCHYME CELL; MONONUCLEAR CELL; NEUTROPHIL; PROCESS OPTIMIZATION; STEM CELL; T LYMPHOCYTE; THROMBOCYTE; UMBILICAL CORD BLOOD;

EID: 4544271598     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/14653240410004871     Document Type: Article

References (12)

1. Jaroscak J, Martin PL, Waters-Pick B et al. A phase I trial of augmentation of unrelated umbilical cord blood transplantation with ex-vivo expanded cells. Blood 1998;92(suppl 1):646a.
2. Stiff P, Pecora A, Parthasarathy M et al. Umbilical cord blood transplants in adults using a combination of unexpanded and ex vivo expanded cells: preliminary clinical observations. Blood 1998;92(suppl 1):646a.
3. Shpall EJ, Quinones R, Hami L et al. Transplantation of ex vivo expanded cord blood cells. BBMT 2002;8:368-76.
4. + cells is essential for optimal ex vivo expansion of umbilical cord blood cells. Exp Hematol 1996;24:1055.
5. - progenitor to maintain primitive function and immunophenotype in vitro. Exp Hematol 1998;26:612-19.
6. Verfaillie CM, Catanzarro PM, Li W-N. Macrophage inflammatory protein 1a, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro. J Exp Med 1994;179:643-49.
7. Rubenstein P, Dobrila L, Rosenfield RE et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995;92:10119-22.
8. Ploemacher RE, van der Sluijs JP, Voerman JSA, Brons NHC. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood 1989; 74:2755-63.
9. Laughlin M, Barker J, Bambach B et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Eng J Med 2001;344:1815-22.
10. Long GD, Laughlin M, Madan B et al. Unrelated umbilical cord blood transplantation in adult patients. BBMT 2003;9:772-80.
11. McNiece I, Jones R, Bearman S et al. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery in breast cancer patients following high dose chemotherapy. Blood 2000;96:3001-7.
12. + progenitor cells from bone marrow and G-CSF-mobilized peripheral blood. Exp Hematol 1997;25:1125-39.